Zentek AI Stock Analysis
Zentek (ZAY0) AI Stock Analysis
Zentek
(Frankfurt:ZAY0)
No summary available
Zentek (ZAY0) vs. iShares MSCI Germany ETF (EWG)
- Market Cap
- EUR 62.30M
- Dividend Yield
- ―
- Average Volume (3M)
- 2,595
- Price to Earnings (P/E)
- 8.0
- Beta (1Y)
- 0.50
- Revenue Growth
- -89.01%
- EPS Growth
- ―
- Country
- Germany
- Employees
- 24
- Sector
- Basic Materials
- Sector Strength
- 61
- Industry
- Medical - Instruments & Supplies
Zentek Business Overview & Revenue Model
Company Description
Zentek Ltd. engages in the research and development of graphene and related nanomaterials in Canada. It owns 100% interest in the Albany Graphite project located in Northern Ontario, Canada. The company develops graphene-based antimicrobial coating u...
Zentek Peers Comparison
Overall Rating
TSE:MDP63Neutral
TSE:ARCH43Neutral
TSE:BUX42Neutral
TSE:SONA37Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 63Neutral | CAD 179.44M | -99.08 | -2.49% | ― | 2.62% | -337.50% | |
| Sector * | 61Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |
| 43Neutral | CAD 59.78M | -20.70 | 74.79% | ― | ― | -15.53% | |
| 42Neutral | CAD 44.72M | -31.11 | -250.77% | ― | -82.05% | 23.73% | |
| 37Underperform | CAD 31.93M | -12.15 | 448.05% | ― | ― | 24.65% |
* Basic Materials Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| DE:ZAY0 | Zentek Ltd. | 0.33 | -0.30 | -47.30% | |
| TSE:ARCH | Arch Biopartners | 0.88 | -0.17 | -16.19% | |
| TSE:BUX | BioMark Diagnostics | 0.42 | 0.07 | 20.00% | |
| TSE:MDP | Medexus Pharmaceuticals | 5.71 | 3.00 | 110.70% | |
| TSE:SONA | Sona Nanotech, Inc | 0.26 | -0.24 | -48.00% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
